Professor @ University of British Columbia
Dr. Pieter Cullis, PhD, FRSC, is a Professor of Biochemistry and Molecular Biology in the Faculty of Medicine of The University of British Columbia (UBC). He is also the Director of the Life Sciences Institute and of the NanoMedicines Research Group, and Chair of the Personalized Medicine Initiative at UBC. He Chairs the Board of Directors of AllerGen NCE Inc.
Dr. Cullis is an internationally recognized pioneer and leader in the physical properties and functional roles of lipids in biological membranes and liposomal drug delivery systems. His laboratory has been responsible for fundamental advances in the generation, loading and targeting of liposomal systems for intravenous delivery of conventional and genetic drugs. This work has led to two products that have been approved by regulatory agencies in the U.S. and Europe for the treatment of cancer and its complications, one that is in late stage (Phase III) clinical trials and two more that are about to enter Phase I studies.
Dr. Cullis has published over 300 scientific articles and is an inventor on over 30 patents. He has received many awards and recognitions, including, in 2011, the prestigious Prix Galien Canada award and the Bill and Marilyn Webber Lifetime Achievement Award.